Didemnins are cytotoxic agents belonging to a depsipeptide family isol
ated from marine tunicates. In the present study, a new member, dehydr
odidemnin B (DDB), isolated from the mediterranean tunicate Aplidium a
lbicans, was used. The effect of the drugs on human colon cultured cel
l lines was tested using multiple approaches: proliferation studies, l
ong term survival after three hours of exposure to DDB by means of a c
lonogenic assay and the decrease of the protooncogen, ornithine decarb
oxylase, activity. A dehydrodidemnin B concentration of 10(-8) M compl
etely inhibited cell growth. The IC50 obtained using the MTT prolifera
tion test, indicated that the most proliferative cell line (CT-2) was
the most sensitive to the drug. Using a clonogenic assay a clear dose-
response was obtained for the three cell lines used; HT-29 cell line s
howed the minimum survival after 3 hours of dehydrodidemnin B treatmen
t. A dose-dependent decrease in ornithine decarboxylase activity was a
lso observed in three cell lines assayed. The data presented indicate
that the dehydrodidemnin B is a potent cytotoxic agent on rapidly divi
ding human colon cancer cells.